About Therapixel
Therapixel is a leading French software company specializing in artificial intelligence applied to medical imaging. Established in 2013, it focuses on developing innovative solutions to enhance radiology practices and improve breast cancer detection through technologies like MammoScreen.
What Therapixel offers
- MammoScreen®: AI software for reading digital mammograms.
- Deep Learning: Algorithm trained on extensive datasets to detect cancer lesions.
- ISO 13485 Compliance: Adherence to medical device quality standards.
- FDA Cleared and CE Marked: Certifying its safety and efficacy in the medical field.
What sets Therapixel apart
- Enhances breast cancer detection accuracy.
- Facilitates efficient access to crucial medical images.
- Developed by a team of experts in applied mathematics and computer vision.